Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

Caplin Point Laboratories share price gains 4% on US FDA nod

The share touched a 52-week high of Rs 686 and a 52-week low of Rs 300.10 on 07 August 2020 and 22 April 2020, respectively.

April 22, 2021 / 10:05 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Caplin Point Laboratories share price gained 4 percent on April 22 after a subsidiary of the company received the nod from the United States Food and Drug Administration (US FDA) for Neostigmine Methylsulfate Injection.

"Caplin Steriles, a subsidiary company of Caplin Point Laboratories, has been granted final approval from the US FDA for its Abbreviated New Drug Application (ANDA) Neostigmine Methylsulfate Injection USP, 5 mg/10 mL (0.5 mg/mL) and 10 mg/10 mL (1 mg/mL), Multiple-Dose vial presentations," company said in a statement to the exchanges.

Neostigmine Methylsulfate Injection is a generic therapeutic equivalent version of (RLD), BLOXIVERZ Injection, of Exela Pharma Sciences, LLC, USA.

Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is used for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery.

"According to IQVIATM (IMS Health), Neostigmine Methylsulfate Injection had US sales data of approximately USD 20 million for the 12-month period ending Dec 2020," the company added.

Close

Recently, the said subsidiary was granted final approval from US FDA for ANDA Milrinone Lactate Injection USP, 10 mg/10 mL (1 mg/mL), 20 mg/20 mL (1 mg/mL), 50 mg/50 mL (1 mg/mL), Single-dose vial presentation.

caplin

At 09:46 hrs, Caplin Point Laboratories was quoting at Rs 523.15, up Rs 15.95, or 3.14 percent on the BSE.

The share touched a 52-week high of Rs 686 and a 52-week low of Rs 300.10 on 07 August 2020 and 22 April 2020, respectively.

Currently, it is trading 23.74 percent below its 52-week high and 74.33 percent above its 52-week low.
Moneycontrol News
first published: Apr 22, 2021 10:05 am

stay updated

Get Daily News on your Browser
Sections